These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34002696)

  • 21. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells.
    Silwal AP; Lu HP
    ACS Chem Neurosci; 2018 Dec; 9(12):3117-3127. PubMed ID: 30024721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein.
    Hamilton PJ; Belovich AN; Khelashvili G; Saunders C; Erreger K; Javitch JA; Sitte HH; Weinstein H; Matthies HJG; Galli A
    Nat Chem Biol; 2014 Jul; 10(7):582-589. PubMed ID: 24880859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD.
    Hansen FH; Skjørringe T; Yasmeen S; Arends NV; Sahai MA; Erreger K; Andreassen TF; Holy M; Hamilton PJ; Neergheen V; Karlsborg M; Newman AH; Pope S; Heales SJ; Friberg L; Law I; Pinborg LH; Sitte HH; Loland C; Shi L; Weinstein H; Galli A; Hjermind LE; Møller LB; Gether U
    J Clin Invest; 2014 Jul; 124(7):3107-20. PubMed ID: 24911152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
    Kahlig KM; Javitch JA; Galli A
    J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.
    Robinson SB; Hardaway JA; Hardie SL; Wright J; Glynn RM; Bermingham DP; Han Q; Sturgeon SM; Freeman P; Blakely RD
    Mol Cell Neurosci; 2017 Jan; 78():41-51. PubMed ID: 27913309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raman Spectroscopic Signature Markers of Dopamine-Human Dopamine Transporter Interaction in Living Cells.
    Silwal AP; Yadav R; Sprague JE; Lu HP
    ACS Chem Neurosci; 2017 Jul; 8(7):1510-1518. PubMed ID: 28375605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT).
    Zwartsen A; Litjens CHC; Hondebrink L; van den Heuvel JJMW; Greupink R; Russel FGM; de Lange DW; Legler J; Koenderink JB; Westerink RHS
    Toxicology; 2019 Jun; 422():69-75. PubMed ID: 31009648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation.
    Guptaroy B; Zhang M; Bowton E; Binda F; Shi L; Weinstein H; Galli A; Javitch JA; Neubig RR; Gnegy ME
    Mol Pharmacol; 2009 Mar; 75(3):514-24. PubMed ID: 19098122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.
    Quizon PM; Yuan Y; Zhu Y; Zhou Y; Strauss MJ; Sun WL; Zhan CG; Zhu J
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):854-869. PubMed ID: 33537927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine Transporter Deficiency Syndrome (DTDS): Expanding the Clinical Phenotype and Precision Medicine Approaches.
    Ng J; Barral S; Waddington SN; Kurian MA
    Cells; 2023 Jun; 12(13):. PubMed ID: 37443770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.
    Cagle BS; Sturgeon ML; O'Brien JB; Wilkinson JC; Cornell RA; Roman DL; Doorn JA
    Toxicol In Vitro; 2021 Oct; 76():105210. PubMed ID: 34252731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome.
    Illiano P; Bass CE; Fichera L; Mus L; Budygin EA; Sotnikova TD; Leo D; Espinoza S; Gainetdinov RR
    Sci Rep; 2017 Apr; 7():46280. PubMed ID: 28417953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
    Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
    Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C; Vernier P; Sidhu A
    Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.
    Wersinger C; Prou D; Vernier P; Niznik HB; Sidhu A
    Mol Cell Neurosci; 2003 Sep; 24(1):91-105. PubMed ID: 14550771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
    Bowton E; Saunders C; Erreger K; Sakrikar D; Matthies HJ; Sen N; Jessen T; Colbran RJ; Caron MG; Javitch JA; Blakely RD; Galli A
    J Neurosci; 2010 Apr; 30(17):6048-57. PubMed ID: 20427663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.